Introduction
Hereditary haemochromatosis (HHC) is an autosomal et al. in South Australia6 have suggested that the recessive condition whose gene lies on the short arm prevalence of haemochromatosis is significantly of chromosome six, near the HLA locus.1 It causes increased in diabetic patients but their findings have excessive intestinal absorption of dietary iron, the not been confirmed in European diabetic clinics lifelong accumulation of which results in its deposition (O'Brien, 1990, 7 Singh et al., 19928) . The aims of the in organs including the liver, heart, pancreas and current study was to determine the prevalence of gonads. Untreated patients frequently develop cirrhohaemochromatosis amongst unselected diabetic sis, often complicated by terminal hepatocellular carpatients in the relatively homogenous and stable cinoma. Long-term survival analyses have found a population in North East England, and to evaluate the normal survival expectation for patients venesected in efficacy of screening such patients routinely. order to deplete total body iron stores, when the Since the completion of this study the cloning of a diagnosis was made before the development of cirrhocandidate gene, HLA-H, two mutations of which were sis. 2-4 Early detection of asymptomatic homozygous found in 87% of patients with HHC, has been individuals can thus reduce morbidity and improve reported,9 and a simple PCR-based test to detect survival, and screening has therefore been advocated. 5 homozygosity in DNA from > 80% of individuals is This is relatively inexpensive and, most importantly, now feasible. detects a condition whose treatment is safe, simple and effective. The cost-effectiveness of population screening is unknown, and targeting of specific highMethods prevalence groups may be preferable. As diabetes is Patients prognostically associated with haemochromatosis in Over a 6-month period, all non-pregnant diabetics 60-80% of patients,2 people assumed to have idiopathic diabetes may constitute such a group. Phelps aged over 16 years, and attending the Diabetes Clinic at the Royal Victoria Infirmary, were offered Table 1 , and the characteristics of patients undergoing liver biopsy, in Table 2 . screening by sampling 15 ml venous blood under non-fasting conditions. Informed verbal consent was Initial screening yielded 54 patients (7.4%) with possible iron overload, 39 of whom had an elevated obtained, and the study was approved by the local joint ethics committee. serum ferritin, 13 a transferrin saturation >55%, and two with both criteria abnormal. Of the 39 with an elevated serum ferritin (21 male, mean age 61.5
Screening years) 20 had normal iron indices on repeat sampling. Four females aged >60 years had a repeat ferritin Serum ferritin was measured by a double-antibody between 250 and 350 mg/l. All four were HLA typed, technique on a Stratus immunoanalyser using a and none carried types A3 or B7 (associated with commercial kit (Baxter Diagnostics). Serum iron was 70% of cases of genetic haemochromatosis1). They measured on an Olympus 560 analyser set at were not offered biopsy. Five males aged >65 years 590 nm, using 2,4,6-tripyridyl-S-triazine reagent.
had a repeat ferritin lying between 350 and 500 mg/l. Male patients with a serum ferritin >350 mg/l, All had normal tests of liver function, were deemed females with a serum ferritin >250 mg/l and any to be of low risk and thus none underwent liver patient with a transferrin saturation >55% were biopsy. The remaining ten patients, all of whom had recalled for repeat sampling. If their results remained type 2 diabetes, had persistently raised ferritin values indicative of iron overload, then liver biopsy was and underwent liver biopsy. Sufficient tissue to allow offered after full clinical assessment. Written, liver iron estimation was obtained in seven, in all of informed consent was obtained, and biopsies were whom the liver iron index lay below 1.5. performed under ultrasound guidance, using a modiHistologically, four of the ten had Grade 1 haemofied Tru-cut needle and 'Biopty' gun. In patients siderosis of no significance and none had aged >70 years, in whom the initial tests indicated haemochromatosis. However, all ten had macrovesonly equivocal iron overload, HLA testing was done icular steatosis, and six had at least early fibrosis. in lieu of liver biopsy, which was not deemed
Of the thirteen patients with an elevated transferrin ethically justifiable. The liver biopsy sample was saturation alone (all male, mean age 40.2 years) divided for histology and liver iron estimation.
eleven had normal values on repeat, one declined Sections were routinely cut at 4 mm from formalinre-screening (26-year-old male, transferrin saturation fixed, paraffin-embedded samples and stained with 68%, serum ferritin 63 mg/l) and one underwent liver haematoxylin and eosin, Perls, Van Giesen, Foots biopsy. This was a 22-year-old, insulin-dependent reticulin, PAS (with and without diastase) and Shikata. diabetic male, in whom biopsy confirmed the presThe Perls stain was assessed in a semi-quantitative ence of pre-cirrhotic haemochromatosis. method as described by Scheuer.10 Liver iron content Two patients had both abnormal ferritin and was measured by flame atomic absorption spectrotransferrin saturation on initial screening. On recall, photometry at a wavelength of 248.3 nm. Liver one of these, a 63-year-old male with insulin-(2-8 mg wet weight) was dried at 100°C to a dependent diabetes and a history of alcohol excess, constant weight, dissolved in concentrated nitric acid had an elevated ferritin only and transferrin of 55%. and hydrogen peroxide, and digested in a 700 W Biopsy showed grade 3 haemosiderosis, macrovesicmicrowave oven before dilution and analysis. ular steatosis and mild fibrosis but a normal liver Recovery from standards was 96-102%, and a iron index of <1. The other, a 72-year-old male reference range was established by analysis of with type 2 diabetes, had an elevated ferritin only post-mortem liver specimens with no histological on repeat (450 mg/l) and declined biopsy. evidence of haemochromatosis. Measurement of Forty-seven patients were iron-deficient, and were liver iron levels allowed calculation of the liver iron investigated separately. index (hepatic iron concentration in mmol/g dry In summary, of 727 patients, 22 had abnormal weight/age). Values >1.9 were highly suggestive of iron indices on repeat screening, of whom only one homozygous disease: values <1.5 were regarded as had proven hereditary haemochromatosis by histonormal.11-13 logical and biochemical criteria. In light of the steatosis noted on liver biopsy, further data were collected on ten of the patients biopsied. The values given are means (SD). They and specificity of 86%. Beilby et al. 22 however have It is one of the commonest inherited metabolic suggested that the calculated transferrin index (serum disorders amongst the White population worldwide iron/transferrin) should replace transferrin saturation but is probably underdiagnosed due to its nonin screening studies. To maximize the chances of specific presenting features.
detecting homozygous carriers, and to permit direct A major difficulty with screening programmes to comparison with previous studies, we chose the Bassett criteria for this study. The study reported here date has been determining the most appropriate test is the largest such survey, and examines a relatively steatosis, has long been recognized in diabetes,27 and may progress, as the prevalence of cirrhosis in genetically homogenous population. Of the 727 diabetic patients screened 22 (3%) had persistently diabetics at autopsy is twice the population average. 27,28 Although our patients had relatively wellabnormal iron indices, but only one of these had hereditary haemochromatosis by histological or biocontrolled serum lipids, their mean body mass index was just into the range defined as obese, and these chemical criteria. Assuming a population prevalence of 4/1000, we would have anticipated detecting patients, selected for biopsy on the basis of their iron status, were significantly heavier than the rest approximately three cases in a group this size. Whilst this may simply be related to chance or the previous of the non-insulin-dependent population. Steatosis is not characteristically associated with abnormal iron selecting-out of known cases, this low prevalence raises questions as to the true prevalence of the indices, but obesity and its related disorders, especially diabetes, may cause non-alcoholic steatohepatcondition in North-East England. Haplotype analyses used to refine the position of the HHC gene suggest itis.29 This poorly-defined condition is characterised by steatosis, an inflammatory infiltrate and early a strong founder effect exerted by a common Celtic ancestor,23 and thus different White populations fibrosis. It may progress to cirrhosis in a small minority of patients, but the severity of liver damage worldwide may have variable population frequencies, depending on their ancestry.
does not apear to correlate directly with obesity, hyperlipidaemia or hyperglycaemia.30 It is therefore Approximately a quarter of patients with haemochromatosis have diabetes at the time of possible that iron may have contributed to the liver abnormalities in the study patients, as iron may presentation, although it is a presenting feature in less than 2%.24 Type 1 diabetes and haemocause hepatocyte damage by lipid peroxidation and increased lysosomal fragility, and act as a direct chromatosis do not share common HLA associations, but there is clearly a complex link between iron stimulus to collagen synthesis.17 Obesity in diabetes as a risk factor for hepatic fibrosis warrants further overload and diabetes. The risk of diabetes is increased in these patients if there is a family history study.
Targeted screening for haemochromatosis in diaof type 2 diabetes,24 presumably being a summation of two pathological processes in the pancreas.
betic clinics does not appear to be a more effective exercise than whole population screening as the Despite this close association between the two conditions, we have failed to demonstrate any condition accounts for less than 1% of patients with diabetes,24 and around 0.3% in the present study. increased prevalence of iron overload amongst the population examined. The screening criteria adopted Whilst haemochromatosis should be considered in the differential diagnosis of diabetics with abnormal are at least as sensitive as those used in comparable studies, and yielded 22 patients with persistently liver function tests, such patients are more likely to have steatosis and possibly fibrosis directly as a abnormal iron indices, only one of whom had homozygous disease.This confirms the low positive result of their diabetes. The important issue of early detection of HHC will soon be addressed by the predictive value of an elevated ferritin or transferrin saturation in diabetics,7 and accords with the findings 'new age' of applied genetics.31 of smaller studies from London8 and Cork.7 Even selecting only those diabetics with abnormal liver function yields only the predicted rate of
